Managing Medical Risk in Patients Seeking Psilocybin Therapy
Managing Medical Risk In Patients Seeking Psilocybin Therapy is an online, self-paced course offering healthcare providers comprehensive insights into psilocybin therapy. Gain vital knowledge about psilocybin, its legality, research indications, and learn to manage medical risks in this rapidly evol
Provider
Details
Enrollment
Course Overview
Managing Medical Risk In Patients Seeking Psilocybin Therapy is a comprehensive 2-hour online, CME/CE accredited course designed for healthcare providers interested in broadening their knowledge about this innovative therapeutic option. This comes in response to the emerging research on the medical benefits of psilocybin and its increased approval for medicinal uses in states like Oregon and Colorado, which have spurred a growing number of patients to consider psilocybin-assisted therapy for various health conditions.
The course aims to fill an information gap in the medical community, as many healthcare professionals have not been trained to effectively assess the medical risks associated with psilocybin therapy. This self-paced program provides participants with the tools they need to safely and comfortably evaluate and discuss the relevant medical risks with their patients.
The curriculum is structured into four key modules: 'Background on Psilocybin', 'Psilocybin Legality & the Oregon Psilocybin Services Act', 'Research-Investigated Indications', and 'Managing Medical Risk in Patients Seeking Psilocybin Therapy'. These modules offer a thorough understanding of the basics of psilocybin therapy, its pharmacology, potential drug-drug interactions, the clinical indications for which it has shown promise, and contraindications to its use. It also explores the historical use of psilocybin and how it affects the mind and body.
This course is especially beneficial for primary care providers for adults and psychiatric health practitioners seeking to deepen their insights into the burgeoning field of psychedelic medicine. Upon completion, participants who pass the course are also offered the opportunity to list themselves in the PMA’s Directory of Psilocybin-Informed Clinicians, a first-of-its-kind directory. This allows patients who need a risk assessment before starting psilocybin therapy to easily find a qualified clinician and offers practitioners a unique platform to connect and share knowledge within a broader community.
Who is this for?
Healthcare providers and other healthcare professionals
About the Provider
The Psychedelic Medicine Association (PMA) is a professional association that educates and connects healthcare practitioners about the therapeutic use of psychedelic medicines. It also develops clinical practice guidelines, training accreditation, and related infrastructure to support safe integration of psychedelic therapies into mainstream healthcare.
View Psychedelic Medicine Association profileCourse Details
- Price$100
- FormatSelf-paced
- Lifecycle statusNo New Dates
- Skillspsilocybin understandinghistorical knowledgelegality comprehensionresearch familiarityrisk managementpharmacology comprehensioninteraction identificationcontraindication recognitionmental effects understandingphysical effects understandingIntegrationFacilitationPsychotherapyKetamine-Assisted Therapy
- Categories
Related Courses
View all coursesATMA Advanced Psychedelic-Assisted Therapy (PAT) Certification Program
By Atma Journey
This course is made for mental health professionals (in Canada) who want to learn how to work with psychedelics. The course staff includes Mark Haden Anthony Bossis, and many more.
Next cohort: Jun 1, 2026
Accredited vs Non-Accredited Psychedelic Training
By AAA Learning Institute
Compare accredited and non-accredited psychedelic training programs, with an overview of what accreditation means and how to evaluate program quality. The page focuses on structure, practicum, curriculum, and practical considerations for prospective psilocybin facilitator students.
Aotearoa New Zealand Psilocybin Training
By Therapsil
A 106-hour live online training in psilocybin-assisted psychotherapy with an Aotearoa New Zealand-specific curriculum, delivered in partnership with PsyTrain. It is designed to support clinical practice with supervised learning and expert faculty input.
Dates not announced